Ken Nesmith

Ken is the cofounder and CEO of Lexent Bio, building liquid biopsy technology to enable better cancer treatment decisions, faster. Prior to Lexent, Ken led product strategy at Counsyl, managing genetic testing and software product teams in reproductive health and oncology. At Noom, as VP of Product Strategy he led international launches of the company’s consumer-facing wellness apps in Germany, Japan, and the UK, achieving top-grossing app ranks, and later launched Noom’s digital health team. He has worked in consulting and banking with BCG and Goldman Sachs, and cofounded Done.com in 2011. He completed his MBA at Wharton. Prior to business school, he was a founding employee at Codon Devices, an industry-pioneering synthetic biology firm. He obtained SBs in Biology and Political Science from MIT.